Effect of carvedilol on coronary flow reserve in patients with hypertensive left-ventricular hypertrophy

References

• Nemes A, Neu K, Forster T, Kovacs Z, Csanady M. Coronary flow velocity reserve is diminished in hypertensive left ventricular hypertrophy. Kardiol Pol. 2005;62:1–5.
   Google Scholar
• Caliskan M, Erdogan D, Gullu H, Ciftci O, Yildirim I, Baycan S, . Association between serum gamma-glutamyltransferase levels and coronary microvascular function in hypertensive patients. J Hypertens. 2007;25:2497–2503.
   Google Scholar
• Chen D, Lin J, Chen J. In patients with hypertensive left ventricular hypertrophy and coronary heart disease, coronary flow reserve is similarly impaired. Chin Med Sci J. 1995; 10:151–157.
   Google Scholar
• Kim W, Jeong MH, Cha KS, Hyun DW, Hur SH, Kim KB, . Effect of anti-oxidant (carvedilol and probucol) loaded stents in a porcine coronary restenosis model. Circ J. 2005; 69:101–106.
   Google Scholar
• Cargnoni A, Ceconi C, Bernocchi P, Boraso A, Parrinello G, Curello S, . Reduction of oxidative stress by carvedilol: Role in maintenance of ischaemic myocardium viability. Cardiovasc Res. 2000;47:556–566.
   PubMed Web of Science ®Google Scholar
• Nakajima T, Ma J, Iida H, Iwasawa K, Jo T, Omata M, . Inhibitory effects of carvedilol on calcium channels in vascular smooth muscle cells. Jpn Heart J. 2003;44:963–978.
   PubMedGoogle Scholar
• Fujio H, Nakamura K, Matsubara H, Kusano KF, Miyaji K, Nagase S, . Carvedilol inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension. J Cardiovasc Pharmacol. 2006;47:250–255.
   Google Scholar
• Vyssoulis GP, Marinakis AG, Aznaouridis KA, Karpanou EA, Arapogianni AN, Cokkinos DV, . The impact of third-generation beta-blocker antihypertensive treatment on endothelial function and the prothrombotic state: Effects of smoking. Am J Hypertens. 2004;17:582–589.
   PubMedGoogle Scholar
• Oettl K, Greilberger J, Zangger K, Haslinger E, Reibnegger G, Jürgens G. Radical-scavenging and iron-chelating properties of carvedilol, an antihypertensive drug with antioxidative activity. Biochem Pharmacol. 2001;62:241–248.
   PubMed Web of Science ®Google Scholar
• Jonsson G, Abdelnoor M, Seljeflot I, Arnesen H, Hostmark AT, Kjeldsen SE, . The antioxidative effects of long-term treatment are more pronounced for carvedilol than for atenolol in post-myocardial infarction patients. J Cardiovasc Pharmacol. 2007;49:27–32.
   PubMed Web of Science ®Google Scholar
• Jonsson G, Fossum E, Kjeldsen SE, Høieggen A, Os I, Eide I, . Lower plasma noradrenaline and blood viscosity on carvedilol vs atenolol in men with recent myocardial infarction. Blood Press. 2002;11:377–384.
   Web of Science ®Google Scholar
• Koepfli P, Wyss CA, Namdar M, Klainguti M, von Schulthess GK, Lüscher TF, . Beta adrenergic blockade and myo-cardial perfusion in coronary artery disease: Differential effects in stenotic versus remote myocardial segments. J Nucl Med. 2004;45:1626–1631.
   Google Scholar
• Kveiborg B, Major-Petersen A, Christiansen B, Torp-Pedersen C. Carvedilol in the treatment of chronic heart failure: Lessons from the Carvedilol Or Metoprolol European Trial. Vasc Health Risk Manag. 2007;3:31–37. Review.
   PubMedGoogle Scholar
• Bank AJ, Kelly AS, Thelen AM, Kaiser DR, Gonzalez-Campoy JM. Effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Hypertens. 2007;20:777–783.
   PubMed Web of Science ®Google Scholar
• Eichhorn EJ, Bristow MR. The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Curr control trials Cardiovasc Med. 2001;2:20–23.
   Google Scholar
• Walther G, Nottin S, Karpoff L, Pérez-Martin A, Dauzat M, Obert P. Flow-mediated dilation and exercise-induced hyper-aemia in highly trained athletes: Comparison of the upper and lower limb vasculature. Acta Physiol (Oxf). 2008;193:139–150.
   Google Scholar
• Caliskan M, Erdogan D, Gullu H, Ciftci O, Yildirim I, Baycan S, . Association between serum gamma-glutamyltransferase levels and coronary microvascular function in hypertensive patients. J Hypertens. 2007;25:2497–2503.
   PubMed Web of Science ®Google Scholar
• Galderisi M, Cicala S, D’Errico A, de Divitiis O, de Simone G. Nebivolol improves coronary flow reserve in hypertensive patients without coronary heart disease. J Hypertens. 2004;22:2201–2208.
   PubMed Web of Science ®Google Scholar
• Rozenberg VD, Nepomnyashchikh LM. Pathomorphology of variant relationships between left ventricle and interventri-cular septum in hypertensive heart. Bull Exp Biol Med. 2007;144:103–107.
   Google Scholar
• Palmieri V, Storto G, Arezzi E, Pellegrino T, Mancini M, Di Minno G, . Relations of left ventricular mass and systolic function to endothelial function and coronary flow reserve in healthy, new discovered hypertensive subjects. J Hum Hypertens. 2005;19:941–950.
   Google Scholar
• Galderisi M, Cicala S, De Simone L, Caso P, Petrocelli A, Pietropaolo L, . Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy. Ital Heart J. 2001;2:677–684.
   Google Scholar
• Plantinga Y, Ghiadoni L, Magagna A, Giannarelli C, Penno G, Pucci L, . Peripheral wave reflection and endothelial function in untreated essential hypertensive patients with and without the metabolic syndrome. J Hypertens. 2008;26:1216–1222.
   Google Scholar
• Higashi Y, Noma K, Yoshizumi M, Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ J. 2009;73:411–418.
   PubMed Web of Science ®Google Scholar
• Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol. 2003;91:7A–11A.
   PubMed Web of Science ®Google Scholar
• Mörtsell D, Malmqvist K, Held C, Kahan T. Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: The Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study. J Intern Med. 2007;261:472–479.
   PubMed Web of Science ®Google Scholar
• Tedesco MA, Natale F, Mocerino R, Tassinario G, Zhang YJ, Xiang MX, . Renal resistive index and cardiovascular organ damage in a large population of hypertensive patients. J Hum Hypertens. 2007;21:291–296.
   PubMed Web of Science ®Google Scholar
• de Gregorio C, Micari A, Grimaldi P, Bragadeesh T, Arrigo F, Coglitore S. Behavior of both epicardial and intramural coronary artery flow velocities in various models of myocardial hypertrophy: Role for left ventricular outflow tract obstruction. Am Heart J. 2005;149:1091–1098.
   Google Scholar
• Takiuchi S, Rakugi H, Fujii H, Kamide K, Horio T, Nakatani S, . Carotid intima-media thickness is correlated with impairment of coronary flow reserve in hypertensive patients without coronary artery disease. Hypertens Res. 2003;26:945–951.
   Google Scholar
• Galderisi M, de Simone G, D’Errico A, Sidiropulos M, Viceconti R, Chinali M, . Independent association of coronary flow reserve with left ventricular relaxation and filling pressure in arterial hypertension. Am J Hypertens. 2008;21:1040–1046.
   PubMed Web of Science ®Google Scholar
• Khalil A, Sareen R, Mallika V, Chowdhury V. Non-invasive evaluation of endothelial function, arterial mechanics and nitric oxide levels in children of hypertensive parents. Indian Heart J. 2008;60:34–38.
   Google Scholar
• Shirwany A, Weber KT. Extracellular matrix remodeling in hypertensive heart disease. J Am Coll Cardiol. 2006;48:97–98.
   Google Scholar
• Flamant M, Placier S, Dubroca C, Esposito B, Lopes I, Chatziantoniou C, . Role of matrix metalloproteinases in early hypertensive vascular remodeling. Hypertension. 2007;50:212–218.
   PubMed Web of Science ®Google Scholar
• Grimm D, Huber M, Jabusch HC, Shakibaei M, Fredersdorf S, Paul M, . Extracellular matrix proteins in cardiac fibrob-lasts derived from rat hearts with chronic pressure overload: Effects of beta-receptor blockade. J Mol Cell Cardiol. 2001;33:487–501.
   PubMed Web of Science ®Google Scholar
• Zhang YJ, Xiang MX, San J, Cheng G, Wang SS. Effect of matrine and carvedilol on collagen and MMPs activity of hypertrophy myocardium induced by pressure overload. J Zhejiang Univ Sci B. 2006;7:245–250.
   Google Scholar